These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3093434)

  • 1. Studies on lipoxygenase inhibitors. II. KF8940 (2-n-heptyl-4-hydroxyquinoline-N-oxide), a potent and selective inhibitor of 5-lipoxygenase, produced by Pseudomonas methanica.
    Kitamura S; Hashizume K; Iida T; Miyashita E; Shirahata K; Kase H
    J Antibiot (Tokyo); 1986 Aug; 39(8):1160-6. PubMed ID: 3093434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on lipoxygenase inhibitors. I. MY3-469 (3-methoxytropolone), a potent and selective inhibitor of 12-lipoxygenase, produced by Streptoverticillium hadanonense KY11449.
    Kitamura S; Iida T; Shirahata K; Kase H
    J Antibiot (Tokyo); 1986 Apr; 39(4):589-93. PubMed ID: 3086266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory activities and inhibition specificities of caffeic acid derivatives and related compounds toward 5-lipoxygenase.
    Sugiura M; Naito Y; Yamaura Y; Fukaya C; Yokoyama K
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1039-43. PubMed ID: 2766406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-656,224 (7-chloro-2-[(4-methoxyphenyl)methyl]-3- methyl-5-propyl-4-benzofuranol): a novel, selective, orally active 5-lipoxygenase inhibitor.
    Belanger P; Maycock A; Guindon Y; Bach T; Dollob AL; Dufresne C; Ford-Hutchinson AW; Gale PH; Hopple S; Lau CK
    Can J Physiol Pharmacol; 1987 Dec; 65(12):2441-8. PubMed ID: 2835137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-substituted-1-naphthols as potent 5-lipoxygenase inhibitors with topical antiinflammatory activity.
    Batt DG; Maynard GD; Petraitis JJ; Shaw JE; Galbraith W; Harris RR
    J Med Chem; 1990 Jan; 33(1):360-70. PubMed ID: 2104936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses of 5,6,7- and 5,7,8-trioxygenated 3',4'-dihydroxyflavones having alkoxy groups and their inhibitory activities against arachidonate 5-lipoxygenase.
    Horie T; Tsukayama M; Kourai H; Yokoyama C; Furukawa M; Yoshimoto T; Yamamoto S; Watanabe-Kohno S; Ohata K
    J Med Chem; 1986 Nov; 29(11):2256-62. PubMed ID: 3783588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa.
    Machan ZA; Taylor GW; Pitt TL; Cole PJ; Wilson R
    J Antimicrob Chemother; 1992 Nov; 30(5):615-23. PubMed ID: 1493979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses of 5,7,8- and 5,6,7-trioxygenated 3-alkyl-3',4'-dihydroxyflavones and their inhibitory activities against arachidonate 5-lipoxygenase.
    Horie T; Tominaga H; Kawamura Y; Hada T; Ueda N; Amano Y; Yamamoto S
    J Med Chem; 1991 Jul; 34(7):2169-76. PubMed ID: 2066991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of a novel class of 5-lipoxygenase inhibitors. 2-(Phenylmethyl)-4-hydroxy-3,5-dialkylbenzofurans: the development of L-656,224.
    Lau CK; Bélanger PC; Scheigetz J; Dufresne C; Williams HW; Maycock AL; Guindon Y; Bach T; Dallob AL; Denis D
    J Med Chem; 1989 Jun; 32(6):1190-7. PubMed ID: 2542553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and 5-lipoxygenase-inhibiting properties of 1-thio-substituted butadienes.
    Hanko R; Hammond MD; Fruchtmann R; Pfitzner J; Place GA
    J Med Chem; 1990 Apr; 33(4):1163-70. PubMed ID: 2319562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids: potent inhibitors of arachidonate 5-lipoxygenase.
    Yoshimoto T; Furukawa M; Yamamoto S; Horie T; Watanabe-Kohno S
    Biochem Biophys Res Commun; 1983 Oct; 116(2):612-8. PubMed ID: 6418162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing 5-lipoxygenase inhibitory activities by oxidative conversion of o-methoxyphenols to catechols using a Cu2(+)-ascorbic acid-O2 system.
    Aihara K; Higuchi T; Hirobe M
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):842-4. PubMed ID: 2347031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
    Tateson JE; Randall RW; Reynolds CH; Jackson WP; Bhattacherjee P; Salmon JA; Garland LG
    Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of the influence of flavonoids on lipoxygenase and cyclooxygenase activity, as well as on nonenzymic lipid oxidation.
    Robak J; Shridi F; Wolbís M; Królikowska M
    Pol J Pharmacol Pharm; 1988; 40(5):451-8. PubMed ID: 3151014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5-lipoxygenase inhibition on cardiac anaphylaxis in isolated guinea pig hearts.
    Jolly SR; Travis J; Van Inwegen RG
    Pharmacology; 1989; 38(6):352-62. PubMed ID: 2813496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a 5-lipoxygenase inhibitor, REV-5901, on leukotriene and histamine release from human lung tissue in-vitro.
    Tennant CM; Seale JP; Temple DM
    J Pharm Pharmacol; 1987 Apr; 39(4):309-11. PubMed ID: 2438401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids.
    Moroney MA; Alcaraz MJ; Forder RA; Carey F; Hoult JR
    J Pharm Pharmacol; 1988 Nov; 40(11):787-92. PubMed ID: 2907559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gossypol, a potent inhibitor of arachidonate 5- and 12-lipoxygenases.
    Hamasaki Y; Tai HH
    Biochim Biophys Acta; 1985 Mar; 834(1):37-41. PubMed ID: 3919771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and 5-lipoxygenase inhibitory activity of 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid analogues.
    Kerdesky FA; Schmidt SP; Holms JH; Dyer RD; Carter GW; Brooks DW
    J Med Chem; 1987 Jul; 30(7):1177-86. PubMed ID: 3599023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential inhibition of 5-lipoxygenase activity by manoalide.
    De Vries GW; Amdahl L; Mobasser A; Wenzel M; Wheeler LA
    Biochem Pharmacol; 1988 Aug; 37(15):2899-905. PubMed ID: 2840081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.